Group One Trading, L.P. Dia Medica Therapeutics Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.05 - $2.99 $9,928 - $14,480	4,843 New	4,843 $13,000
Q2 2022 Aug 11, 2022	SELL	$1.86 - $2.62 $37 - $52	-20 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.29 - $3.88 $77,511 - $131,330	-33,848 Reduced 99.94%	20 $0
Q4 2021 Feb 11, 2022	BUY	$3.43 - $4.65 $33,099 - $44,872	9,650 Added 39.85%	33,868 $126,000
Q3 2021 Nov 12, 2021	BUY	$3.1 - $4.32 $63,537 - $88,542	20,496 Added 550.67%	24,218 $97,000
Q2 2021 Aug 10, 2021	BUY	$4.45 - $9.91 $16,562 - $36,885	3,722 New	3,722 $17,000

4.22M

8.2K

200

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $118M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.